Esophageal cancer: Epidemiology, pathogenesis and prevention

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 5, Issue 9, 2008, Pages 517-526

  Umar, Sarah B ^a   Fleischer, David E ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALLYL SULFIDE; CYCLOOXYGENASE 2 INHIBITOR; ELLAGIC ACID; N BENZYL N METHYLNITROSAMINE; NONSTEROID ANTIINFLAMMATORY AGENT; SELENIUM;

ALCOHOL CONSUMPTION; BARRETT ESOPHAGUS; CANCER INCIDENCE; CANCER INHIBITION; CANCER MORTALITY; CANCER RISK; CANCER SCREENING; CANCER SURVIVAL; CARCINOGENESIS; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DIETARY INTAKE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS CANCER; ESOPHAGUS DISEASE; ESOPHAGUS RESECTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GEOGRAPHIC DISTRIBUTION; HELICOBACTER INFECTION; HERITABILITY; HUMAN; NONHUMAN; OBESITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SEX DIFFERENCE; SMOKING; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE;

ADENOCARCINOMA; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; HUMANS; RISK FACTORS;

EID: 51349115004     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep1223     Document Type: Review

References (79)

1. Espey DK et al. (2007) Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer 110: 2119-2152
2. Blot WJ and McLaughlin JK (1999) The changing epidemiology of esophageal cancer. Semin Oncol 26: 2-8
3. Holmes RS and Vaughan TL (2007) Epidemiology and pathogenesis of esophageal cancer. Semin Radiat Oncol 17: 2-9
4. Baquet CR et al. (2005) Esophageal cancer epidemiology in blacks and whites: Racial and gender disparities in incidence, mortality, survival rates and histology. J Natl Med Assoc 97: 1471-1478
5. Wu X et al. (2007) Incidence of esophageal and gastric cancers among Hispanics, non-Hispanic whites and non-Hispanic blacks in the United States: Subsite and histology differences. Cancer Causes Control 18: 585-593
6. Kubo A and Corley DA (2004) Marked multi-ethnic variation of esophageal and gastric cardia carcinomas within the United States. Am J Gastroenterol 99: 582-588
7. Lambert R and Hainaut P (2007) Esophageal cancer: Cases and causes (part 1). Endoscopy 39: 550-555
8. [No authors listed] (2002) Cancer incidence in five continents: Volume VIII. IARC Sci Pub 155: 1-781
9. Falk GW (2002) Barrett's esophagus. Gastroenterology 122: 1569-1591
10. Drewitz DJ et al. (1997) The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 92: 212-215
11. Lieberman D et al. (2004) Endoscopic evaluation of patients with dyspepsia: Results from the national endoscopic data repository. Gastroenterology 127: 1067-1075
12. Rastogi A et al. (2008) Incidence of esophageal adenocarcinoma in patients with Barretts esophagus and high-grade dysplasia: A meta-analysis. Gastrointest Endosc 67: 394-398
13. Rabinovitch PS et al. (2001) Predictors of progression in Barrett's esophagus III: Baseline flow cytometric variables. Am J Gastroenterol 96: 3071-3083
14. Kerkhof M et al. (2007) Biomarkers for risk stratification of neoplastic progression in Barrett esophagus. Cell Oncol 29: 507-517
15. Freedman ND et al. (2007) A prospective study of tobacco, alcohol, and the risk of esophageal and gastric cancer subtypes. Am J Epidemiol 165: 1424-1433
16. Vaughan TL et al. (1995) Obesity; alcohol, and tobacco as risk factors for cancers of the esophagus and gastric cardia: Adenocarcinoma versus squamous cell carcinoma. Cancer Epidemiol Biomarkers Prev 4: 85-92
17. Zambon P et al. (2000) Smoking, type of alcoholic beverage and squamous-cell oesophageal cancer in northern Italy. Int J Cancer 86: 144-149
18. Gammon MD et al. (1997) Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 89: 1277-1284
19. Hiyama T et al. (2007) Genetic polymorphisms and esophageal cancer risk. Int J Cancer 121: 1643-1658
20. Lee CH et al. (2007) Carcinogenetic impact of alcohol intake on squamous cell carcinoma risk of the oesophagus in relation to tobacco smoking. Eur J Cancer 43: 1188-1199
21. Yang SJ et al. (2007) Genetic potymorphisms of ADH2 and ALDH2 association with esophageal cancer risk in southwest China. World J Gastroenterol 13: 5760-5764
22. Calle EE et al. (2003) Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348: 1625-1638
23. Samanic C et al. (2006) Relation of body mass index to cancer risk in 362,552 Swedish men. Cancer Causes Control 17: 901-909
24. Smith M et al. (2008) Esophageal cancer and body mass index: results from a prospective study of 220,000 men in China and a meta-analysis of published studies. Int J Cancer 122: 1604-1610
25. Brown LM et al. (1995) Adenocarcinoma of the esophagus: Role of obesity and diet. J Natl Cancer Inst 87: 104-109
26. Smith KJ et al. (2005) Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 14: 2481-2486
27. Edelstein ZR et al. (2005) Central adiposity and risk of Barrett's esophagus. Gastroenterology 133: 403-411
28. De Stefani E et al. (2003) Food groups and risk of squamous cell carcinoma of the oesophagus: A case-control study in Uruguay. Br J Cancer 89: 1209-1214
29. Sharp L et al. (2001) Risk factors for squamous cell carcinoma of the oesophagus in women: A case-control study. Br J Cancer 85 1667-1670
30. Castellsague X et al. (2000) Influence of mate drinking, hot beverages and diet on esophageal cancer risk in South America. Int J Cancer 88: 658-664
31. Bosetti C et al. (2000) Food groups and risk of squamous cell esophageal cancer in northern Italy. Int J Cancer 87: 289-294
32. De Jong U et al. (1972) The relationship between the ingestion of hot coffee and intraesophageal temperature. Gut 13: 24-30
33. Yokokawa Y et al. (1999) Ecological study on the risks of esophageal cancer in Ci-Xian, China: The importance of nutritional status and the use of well water. Int J Cancer 83: 620-624
34. Freedman ND et al. (2007) Fruit and vegetable intake and esophageal cancer in a large prospective cohort study. Int J Cancer 121: 2753-2760
35. Wu AH et al. (2003) Role of Helicobacter pylori CagA+ strains and risk of adenocarcinoma of the stomach and esophagus. Int J Cancer 103: 815-821
36. Siman JH et al. (2007) Helicobacter pylori and CagA seropositivity and its association with gastric and oesophageal carcinoma. Scand J Gastroenterol 42: 933-940
37. Weston AP et al. (2000) Prospective evaluation of the prevalence of gastric Helicobacter pylori infection in patients with GERD, Barrett's esophagus, Barrett's dysplasia, and Barrett's adenocarcinoma. Am J Gastroenterol 95: 387-394
38. Lord RV et al. (2000) Prevalence of Helicobacter pylori infection in 160 patients with Barrett's oesophagus or Barrett's adenocarcinoma. Aust NZJ Surg 70: 26-33
39. Csendes A et al. (1997) Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus. Dis Esophagus 10: 38-42
40. Rokkas T et al. (2007) Relationship between Helicobacter pylori infection and esophageal neoplasia: A meta-analysis. Clin Gastroenterol Hepatol 5: 1413-1417
41. Kamangar F et al. (2007) Helicabacter pylori and oesophageal and gastric cancers in a prospective study in China. Br J Cancer 96: 172-176
42. Richter JE et al. (1998) Helicobacter pylori and gastroesophageal reflux disease: The bug may not be all bad. Am J Gastroenterol 93: 1800-1802
43. Ye W et al. (2004) Helicobacter pylori infection and gastric atrophy: Risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia. J Natl Cancer Inst 96: 388-396
44. Iijima K et al. (2007) Extensive gastric atrophy: An increased risk factor for superficial esophageal squamous cell carcinoma in Japan. Am J Gastroenterol 102: 1603-1609
45. Sandler RS et al. (1995) The risk of esophageal cancer in patients with achalasia: A population-based study. JAMA 274: 1359-1362
46. Kochhar R et al. (2006) Corrosive induced carcinoma of esophagus: report of three patients and review of literature. J Gastroenterol Hepatol 21: 777-780
47. Xing, D et al. (2003) Genetic polymorphisms and susceptibility to esophageal cancer among Chinese population. Oncol Rep 10: 1615-1623
48. Peters CJ and Fitzgerald RC (2007) Systematic review: The application of molecular pathogenesis to prevention and treatment of oesophageal adenocarcinoma. Aliment Pharmacol Ther 25: 1253-1269
49. Lambert R and Hainaut P (2007) Esophageal cancer: The precursors (Part II). Endoscopy 39: 659-664
50. Chang-Claude J et al. (1997) Familial aggregation of oesophageal cancer in a high incidence area in China. Int J Epidemiol 26 1159-1165
51. Wang YP et al. (1992) Esophageal cancer in Shanxi Province, People's Republic of China: A case-control study in high and moderate risk areas. Cancer Causes Control 3: 107-113
52. Li JY et al. (1989) A case-control study of cancer of the esophagus and gastric cardia in Linxian. Int J Cancer 43: 755-761
53. Iwaya T et al. (1998) Tylosis esophageal cancer locus on chromosome 17q25.1 is commonly deleted in sporadic human esophageal cancer. Gastroenterology 114: 1206-1210
54. Chak A et al. (2002) Familial aggregation of Barrett's oesophagus, oesophageal adenocarcinoma, and oesophagogastric junctional adenocarcinoma in Caucasian adults. Gut 51: 323-328
55. Chak A et al. (2004) Identification of Barrett's esophagus in relatives by endoscopic screening. Am J Gastroenterol 99: 2107-2114
56. Sappati Biyyani RS et al. (2007) Familial trends of inheritance in gastro esophageal reflux disease, Barrett's esophagus and Barrett's adenocarcinoma: 20 families. Dis Esophagus 20: 53-57
57. Polednak AP (2003) Trends in survival for both histologic types of esophageall cancer in US surveillance, epidemiology and end results areas. Int J Cancer 105: 98-100
58. Stoner GD et al. (2007) Chemoprevention of esophageal squamous cell carcinoma. Toxicol Appl Pharmacol 224: 337-349
59. Daniel EM et al. (1989) Extraction, stability and quantitation of ellagic acid in various fruits and nuts. J Food Compost Anal 2 338-349
60. Stoner GD et al. (2007) Cancer prevention with freeze-dried berries and berry components. Semin Cancer Biol 17: 403-410
61. Jaskiewicz K et al. (1988) Selenium and other mineral elements in populations at risk for esophageal cancer. Cancer 62: 2635-2639
62. Mark SD et al. (2000) Prospective study of serum selenium levels and incident esophageal and gastric cancers. J Natl Cancer Inst 92: 1753-1763
63. Limburg PJ et al. (2005) Randomized, placebo-controlled, esophageal squamous cell cancer chemoprevention trial of selenomethionine and celecoxib. Gastroenterology 129: 863-873
64. Zhou QZ et al. (2007) Aspirin inhibits the proliferation of tobacco-related esophageal squamous carcinomas cell lines through cyclooxygenase 2 pathway. Chin Med J 120: 2086-2091
65. Jiang JG et al. (2004) Expression of cyclooxygenase-2 in human esophageal squamous cell carcinomas. World J Gastroenterol 10: 2168-2173
66. Shirvani VN et al. (2000) Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure. Gastroenterology 118: 487-496
67. Mortis CD et al. (2001) Cyclooxygenase-2 expression in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence. Am J Gastroenterol 96: 990-996
68. Ratnasinghe D et al. (1999) Expression of cyclooxygenase-2 in human squamous cell carcinoma of the esophagus; an immunohistochemical survey. Anti cancer Res 19: 171-174
69. Sheng H et al. (1998) Modulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells. Cancer Res 58 362-366
70. Buttar NS et al. (2002) The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: An in vitro study. J Natl Cancer Inst 94: 422-429
71. Vaughan TL et al. (2005) Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett's oesophagus: A prospective study. Lancet Oncol 6: 945-952
72. Bardou M et al. (2004) Effect of chronic intake of NSAIDs and cyclooxygenase 2-selective inhibitors on esophageal cancer incidence. Clin Gastroenterol Hepatol 2: 880-887
73. Duan L et al. (2008) Nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric adenocarcinomas in Los Angeles County. Cancer Epidemiol Biomarkers Prev 17: 126-134
74. Corley DA et al. (2003) Protective association of aspirin/NSAIDs and esophageal cancer: A systematic review and meta-analysis. Gastroenterology 124: 47-56
75. van Sandick JW et al. (1998) Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut 43: 216-222
76. Corley DA et al. (2002) Surveillance and survival in Barrett's adenocarcinomas: A population-based study. Gastroenterology 122 633-640
77. Switzer-Taylor V et al. (2008) Barrett's esophagus: A retrospective analysis of 13 years surveillance. J Gastroenterol Hepatol [doi:10.111/j.1440-1746.2008.05311.x]
78. Wang KK and Sampliner RE (2008) Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus. Am J Gastroenterol 103: 788-797
79. Hirota WK et al. (2006) ASGE guideline: The role of endoscopy in the surveillance of premalignant conditions of the upper GI tract. Gastrointest Endosc 63: 570-580